Generic medicine

Ondansetron 8mg Injection

Reviewed educational reference: what Ondansetron is used for, how it works, its side effects and safety advice, plus the Indian brands that contain it.

Reviewed by Sohan Lal Kushwaha
Molecule
Ondansetron
Strength
8mg
Dosage form
Injection
Drug class
5-HT3 receptor antagonist

Related products

No reviewed products are currently published for this generic.

Ondansetron 8mg Injection is an injectable medication containing Ondansetron, which belongs to the class of 5-HT3 receptor antagonists. It is designed to manage severe nausea and vomiting that often occur during cancer treatment or after major surgery. By blocking the action of serotonin in the brain and gut, Ondansetron 8mg Injection helps patients maintain nutrition and hydration during critical recovery phases. It is widely used in hospital settings due to its rapid onset and high efficacy in preventing acute emesis.

At a glance

Quick look

Ondansetron 8mg Injection is an injectable form of Ondansetron.

How it works

It blocks 5-HT3 receptors to stop nausea and vomiting.

Who it is for

It is used for chemotherapy, radiation, and post-surgery recovery.

Uses it for
CINVRINVPONVSevere NauseaChemotherapy supportSurgical recovery

Uses of Ondansetron

  • Prevention of nausea and vomiting caused by chemotherapy.
  • Management of vomiting resulting from radiotherapy.
  • Prevention of post-operative nausea and vomiting after general anesthesia.
  • Treatment of severe acute nausea in hospital settings.
  • Supportive care for patients undergoing high-dose chemotherapy.
  • Control of vomiting in patients with advanced malignancies.

Benefits of Ondansetron

Rapid Symptom Control. Because Ondansetron 8mg Injection is administered via injection, it bypasses the digestive tract. This allows Ondansetron to reach the chemoreceptor trigger zone quickly, providing fast relief to patients who cannot tolerate oral medications.

High Efficacy in CINV. Ondansetron is specifically effective against the acute phase of chemotherapy induced nausea. It reduces the need for rescue medications and improves the overall quality of life for patients undergoing aggressive cancer therapy.

Side effects of Ondansetron

While generally well-tolerated, Ondansetron 8mg Injection may cause side effects in some individuals. The most frequently reported issue is headache, which is typically mild to moderate in intensity. Constipation is another common observation, often requiring dietary adjustments or stool softeners if it persists. Some patients may experience a sensation of warmth or flushing immediately following the intravenous administration of the injection.

More serious, though rare, side effects include cardiac rhythm disturbances, specifically QT interval prolongation. This is why clinicians monitor patients with pre-existing heart conditions or electrolyte imbalances closely. Rarely, hypersensitivity reactions such as skin rashes or bronchospasm may occur. If you notice any signs of an allergic reaction, such as swelling of the face or difficulty breathing, seek immediate medical attention. Most side effects are transient and resolve once the medication is discontinued or the course of treatment is completed.

Side effectHow commonHow severeWhat to do
HeadacheVery commonMildTake simple analgesics as advised by your doctor.
ConstipationCommonModerateIncrease fluid and fiber intake.
QT ProlongationRareSeverePerform ECG monitoring.

How to manage side effects

Headache

  • 1. Assess severity.
  • 2. Recommend paracetamol if appropriate.
  • 3. Monitor for persistence.

Constipation

  • 1. Review dietary habits.
  • 2. Consider stool softeners if necessary.
  • 3. Ensure adequate hydration.

QT Prolongation

  • 1. Discontinue the drug.
  • 2. Correct electrolyte imbalances.
  • 3. Consult a cardiologist immediately.

How to use Ondansetron

  • Ondansetron 8mg Injection must be administered by a healthcare professional.
  • For intravenous use, it should be given as a slow bolus injection over 2 to 5 minutes.
  • It can be diluted in normal saline or 5 percent dextrose for infusion.
  • Intramuscular injection is an alternative when IV access is not available.
  • The dose is typically 8 mg for adults, though it may vary based on the chemotherapy regimen.

Special population advice

Liver impairment

  • Reduce dose or increase interval as Ondansetron is metabolized by the liver.

Kidney impairment

  • No dose adjustment is generally required for patients with renal failure.

Children

  • Use weight-based dosing, typically 0.15 mg/kg per dose.

Elderly

  • Monitor ECG for QT prolongation as older adults may be more sensitive to cardiac effects.

How Ondansetron works

Ondansetron works by selectively blocking the 5-HT3 serotonin receptors located on the vagus nerve terminals in the gastrointestinal tract and in the chemoreceptor trigger zone of the brain. By inhibiting these receptors, it prevents the transmission of signals that trigger the vomiting reflex, thereby providing significant relief from nausea.

What if you miss or exceed a dose?

If you miss a dose

Since Ondansetron 8mg Injection is given by a nurse or doctor, a missed dose usually happens if a scheduled infusion is delayed. You should inform your medical team immediately. They will decide whether to give the dose late or skip it based on your current symptoms and the timing of your next chemotherapy cycle.

In case of overdose

An overdose of Ondansetron can lead to severe headaches or cardiac issues. The most serious risk is the prolongation of the QT interval, which can cause irregular heartbeats. If too much Ondansetron 8mg Injection is given, the patient requires immediate cardiac monitoring and supportive care to manage heart rhythm changes.

Antidoteno specific antidote

Treatment is supportive and focuses on cardiac stability.

Cardiac Monitoring
Continuous ECG monitoring to detect QT prolongation or arrhythmias.
Hemodynamic Support
Maintenance of blood pressure and fluid balance via IV fluids.
Symptomatic Relief
Management of severe headache or agitation using appropriate supportive care.
Observation
Close monitoring of respiratory and neurological status until the drug is cleared.

Safety and precautions

When to avoid Ondansetron

Do not take if you
  • Hypersensitivity

    Known allergy to Ondansetron or other 5-HT3 antagonists.

  • Apomorphine use

    Concurrent use with apomorphine is strictly contraindicated.

Use with caution
  • Cardiac disease

    Risk of QT prolongation and arrhythmias.

  • Electrolyte imbalance

    Correct hypokalemia or hypomagnesemia before administration.

  • Hepatic impairment

    Reduce dose in patients with severe liver disease.

  • Gastrointestinal obstruction

    Monitor for signs of bowel obstruction.

Safety at a glance

AlcoholUse with caution

Alcohol may worsen nausea and increase the risk of side effects.

PregnancyConsult your doctor

Use only if clearly indicated and under strict medical supervision.

BreastfeedingConsult your doctor

Consult your doctor as the drug may pass into breast milk.

DrivingSafe

Generally does not affect alertness, but avoid driving if you feel unwell.

KidneySafe

No dose adjustment is typically required for renal impairment.

LiverUse with caution

Dose reduction may be necessary in patients with severe hepatic impairment.

AllergyUnsafe

Do not use if you have a known hypersensitivity to 5-HT3 antagonists.

ChildrenUse with caution

Use only under pediatric specialist guidance with weight-based dosing.

ElderlyUse with caution

Monitor closely for cardiac effects and constipation.

Interactions

With other medicines

Amiodarone

Major

Changes the medicine’s effect

What can happen: Increased risk of QT prolongation and Torsades de Pointes.

What to do: Avoid concurrent use or monitor ECG closely.

Rifampicin

Moderate

Changes how the medicine is processed

What can happen: Reduced plasma concentration of Ondansetron.

What to do: Monitor for reduced antiemetic efficacy.

Apomorphine

Major

Should not be combined

What can happen: Severe hypotension and loss of consciousness.

What to do: Do not use together under any circumstances.

With food and drink

  • None specificMinor

    No significant food interactions are known for this injection.

  • Grapefruit juiceMinor

    May theoretically alter hepatic metabolism enzymes, though clinically insignificant for IV administration.

If you have another condition

  • Congenital long QT syndrome

    Avoid use due to high risk of life-threatening arrhythmias.

  • Severe hepatic impairment

    Requires dose adjustment to prevent accumulation.

Effect on laboratory tests

  • ECG

    <b>QT interval prolongation</b>

    Monitor heart rhythm during treatment.

Quick tips

  • Tell your doctor if you have a history of heart rhythm problems before receiving Ondansetron 8mg Injection.
  • Report any sudden dizziness or fainting spells to the nursing staff immediately.
  • Be aware that Ondansetron may cause constipation, so drink plenty of water if allowed.
  • This medication is most effective when given before the trigger, such as before chemotherapy starts.

Counselling points

  • Heart RhythmImportant

    Inform your doctor if you feel palpitations or a racing heart while receiving Ondansetron 8mg Injection.

  • DizzinessGood to know

    You may feel slightly dizzy after the injection. Avoid standing up too quickly.

  • EffectivenessGood to know

    This medicine is meant to prevent vomiting, not always to stop it once it has started.

  • ConstipationOptional

    You might feel constipated. Let the staff know so they can help you manage it.

Monitoring during treatment

Before starting

  • ECG for patients with cardiac risk
  • Serum electrolytes (potassium, magnesium)
  • Liver function tests

During treatment

  • during treatment: Monitor heart rhythm and electrolyte levels if symptoms arise.

What is being watched

  • QT interval
  • Heart rate
  • Electrolyte levels
  • Liver enzymes

Pharmacokinetics

Absorption
Rapidly absorbed following oral administration; injection provides immediate bioavailability.
Bioavailability
Approximately 60% with oral, 100% with IV.
Protein binding
70-76%.
Volume of distribution
1.9 L/kg.
Half-life
3 to 5 hours.
Metabolism
Extensive hepatic metabolism via CYP450 enzymes.
Excretion
Primarily via urine as metabolites.
Onset / duration
Onset within minutes; duration 8-12 hours.

Fact box

Chemical class
Carbazolone derivative
Habit forming
No
Therapeutic class
Antiemetic
Action class
Selective 5-HT3 receptor antagonist
Storage
Store Ondansetron 8mg Injection at room temperature, usually between 20 to 25 degrees Celsius. Protect the vial from direct light. Check the solution for clarity and particles before use.
ATC code
A04AA01
Pregnancy category
B

More information

Clinical Rationale for Selection

Clinicians select Ondansetron as a first-line agent for emesis prevention because of its superior safety profile compared to older dopamine antagonists like metoclopramide. Unlike those agents, Ondansetron does not cross the blood-brain barrier in a way that causes extrapyramidal symptoms such as tremors or dystonia. This makes it the standard of care for oncology patients who are already experiencing significant physical distress. Its high affinity for 5-HT3 receptors ensures that the vomiting reflex is blocked at the source, providing reliable protection during highly emetogenic chemotherapy regimens.

Comparison with Alternatives

When compared to other antiemetics, Ondansetron is distinguished by its lack of sedative effects. While antihistamines or phenothiazines might be used for nausea, they often cause significant drowsiness, which can hinder a patient's recovery or daily functioning. Newer agents like NK1 receptor antagonists are sometimes used in combination with Ondansetron for highly emetogenic chemotherapy, but Ondansetron remains the backbone of the antiemetic regimen due to its proven efficacy, ease of administration, and well-understood safety profile in both pediatric and adult populations.

Lifestyle and Supportive Care

While receiving treatment with Ondansetron 8mg Injection, patients should focus on maintaining adequate hydration, as nausea can often lead to fluid loss. If constipation occurs, which is a known side effect, increasing dietary fiber and ensuring regular fluid intake is recommended. Patients should avoid strenuous activity immediately after receiving the injection if they feel lightheaded. It is also helpful to keep a log of nausea episodes, as this information is invaluable for the medical team when they are planning subsequent doses or adjusting the treatment strategy for future cycles.

Managing Common Misconceptions

A common misconception is that Ondansetron 8mg Injection will completely eliminate all forms of nausea. While it is highly effective for chemotherapy and surgery-related nausea, it may not be as effective for nausea caused by other factors like motion sickness or certain metabolic disturbances. Patients should also understand that the absence of nausea does not mean the medication has stopped working; it means the medication is successfully preventing the reflex. Finally, patients often worry about the injection itself, but it is a routine procedure that is quick and generally painless when administered by a trained professional.

References

  1. Electronic Medicines Compendium. Ondansetron 2mg/ml Solution for Injection, Summary of Product Characteristics.View sourceAccessed
  2. Pharmacy and Poisons Board Kenya. Setroken Injection, Summary of Product Characteristics.View sourceAccessed
  3. Health Products Regulatory Authority. Ondansetron 2mg/ml Solution for Injection, Summary of Product Characteristics.View sourceAccessed
  4. Medicore Inc. Ondansetron 2mg/ml Injection, Summary of Product Characteristics.View sourceAccessed
  5. Tripathi KD. Essentials of Medical Pharmacology. 8th ed. Jaypee Brothers Medical Publishers, 2019.Accessed

Frequently asked questions about Ondansetron

Does Ondansetron 8mg Injection work for motion sickness?

No, Ondansetron is not indicated for motion sickness or morning sickness in pregnancy.

How long does the effect last?

The effect typically lasts for 24 hours, but it depends on the cause of the nausea.

Can it be given with other drugs?

Yes, it is often used with corticosteroids or dopamine antagonists to increase efficacy.

Is it safe for long term use?

It is usually used for short term acute episodes. Long term use requires medical supervision.

What if I feel a burning sensation at the injection site?

This is a common local reaction. Inform your nurse immediately.

Latest